Developer of an imaging system designed to improve patient outcomes at a reduced cost by applying artificial intelligence to vascular diagnostic imaging. Elucid Bioimaging is based in Boston, MA. It was valued at $288 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $163 million across 3 recorded rounds; the latest was a $36.5 million early-stage round in Oct 2025.
PMV mark · valuation
$288.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$163.2M
Last round
Early Stage VC
Oct 2025
Cap table — not yet on record
Elucid Bioimaging's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Elucid Bioimaging with a free account
·The complete investor list: 24 names
·Watch Elucid Bioimaging: the Monday email on marks, rounds and moves
Where does Elucid Bioimaging's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Elucid Bioimaging's 3 recorded funding rounds.
